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Abstract
Forensic postmortem case interpretation can be challenging, in particular due to postmortem redistri-
bution (PMR) phenomena. Recent studies have shown that computed tomography (CT)-guided collec-
tion of biopsy samples using a robotic arm (virtobot) provides a valuable tool for systematic studies
on time-dependent PMR. Utilizing this strategy, several cases involving opioid use such as metha-
done, fentanyl, tramadol, codeine, oxycodone and hydrocodone were evaluated for time-dependent
concentration changes and potential redistribution mechanisms. Upon admission to the institute (t1),
blood (femoral and right ventricle heart blood) and tissue biopsy samples (lung, kidney, liver, spleen,
thigh muscle and adipose tissue) were collected utilizing CT-guided biopsy. Approximately 24 h later
(t2; mean 28 ± 15h), during the autopsy, samples from the same body regions were collected manually
and in addition brain tissue, gastric content, urine and left ventricle heart blood. Analysis was con-
ducted with liquid chromatography tandem mass spectrometry. Significant time-dependent meth-
adone concentration increases in femoral blood (pB) indicate the occurrence of PMR, however,
ultimately not relevant for forensic interpretation. The main metabolite of methadone, 2-ethylidene-1,5-
dimethyl-3,3-diphenylpyrrolidine (EDDP), showed a less significant trend for PMR. Redistribution by
passive diffusion along the muscle-to-pB concentration gradient seems likely for methadone, but not
for EDDP. Results for fentanyl suggest extensive PMR. Other opioids such as tramadol, codeine, hydro-
codone and oxycodone showed no consistent trend for significant PMR. Overall, CT-guided biopsy
sampling proved to be a valuable tool for the investigation of PMRmechanisms.
Introduction
During the forensic postmortem investigation into the cause and man-
ner of death, a forensic toxicologist aims to determine a legal or illegal
drug intake or application prior to death and attempts to assess the con-
tribution of a drug towards the cause and manner of death. The key
concept in this context is whether or not the concentration of a drug in
a postmortem sample accurately reflects the concentration at time of
death (1). Besides antemortem- (reference values from living people)
and perimortem factors (agonal phase), particularly postmortem factors
may influence case interpretation (2, 3). The anatomical and physiologi-
cal changes that can alter drug concentrations artificially after death are
summarized in the term postmortem redistribution (PMR). Caused by
diffusion processes, degradation or drug neo-formation driven by
microorganisms, significant site- and time-dependent variations in drug
concentrations may be observed compared to time of death (4, 5).
Various studies report, that pH, volume of distribution (Vd), protein
binding affinity, bacterial biotransformation action and lipophilicity
may, upon others, influence the extent of PMR (4, 6, 7).
Opioids are widely used for their pain relieving effects but due to
their highly addictive properties are prone to misuse. The high abu-
sive potential of opioids makes them an important target in forensic
toxicological analyses with a frequent contribution to cause of death.
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According to the Centers for Disease Control and Prevention (CDC) on
average more than 90 Americans died from an opioid overdose every
day based on figures from 2015 (8, 9). Additionally, in October 2017
the ongoing opioid epidemic was declared a nationwide public-health
emergency in the USA (10). Well known in this context is methadone
that is used in methadone maintenance treatment. Further, particularly
fentanyl was brought into the public attention in recent years as an
extensively abused, extremely potent opioid (11, 12). More traditional
substances or metabolites of these, acting on the opioid receptors are
for example codeine, tramadol, hydrocodone and oxycodone. Only few
studies focus on the tendency of opioids undergoing PMR, despite the
fact that due to their physiochemical properties (e.g., large Vd) most
opioids are thought to be prone to PMR. Generally, the predominant
tool to predict the extent of PMR is the cardiac-to-femoral blood con-
centration ratio (C/P-ratio). This was also utilized by some research
groups to assess PMR of methadone and its metabolite 2-ethylidene-
1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) (13–16). As an alterna-
tive approach the liver-to-femoral blood (L/P) ratio was previously used
to estimate the extent of methadone PMR (4). This was based on the
idea that the greater magnitude of the L/P-ratio compared to the C/P-
ratio provides an advantage in interpreting a drug’s potential for PMR
(17). Particularly for fentanyl, the superiority of the L/P-ratio over the
C/P-ratio has been recently addressed (12, 18). However, neither of the
aforementioned ratios have a clear relationship to a drugs’ physiochem-
ical properties such as Vd, pKa and protein binding affinity that are
thought to influence the PMR. Further, time-dependent concentration
changes and the usefulness of alternative matrices are often neglected in
current studies. Following this, the aim of this study was to clarify the
potential of time-dependent PMR of opioids not only in blood but also
in alternative matrices such as muscle, liver, kidney, lung, spleen and
adipose tissue. In this context, the application of computed tomography
(CT)-guided biopsy sampling hours before conventional autopsy should
provide valuable information on drug concentration changes in alterna-
tive matrices (19, 20). Further, redistribution mechanisms should be
investigated particularly for methadone and EDDP.
Materials and Methods
Chemicals and reagents
Methanolic solutions of methadone, EDDP, fentanyl, codeine, oxyco-
done, oxymorphone, dihydrocodeine, hydrocodone, tramadol and O-
desmethyltramadol (ODMT) (1mg/mL) and the deuterated internal
standards (IS) methadone-d9, fentanyl-d5, codeine-d3 (0.1mg/mL) and
tramadol-d3 (1mg/mL) were obtained from Cerilliant (delivered by
Sigma-Aldrich, Buchs, Switzerland). Water was purified with a Purelab
Ultra Millipore filtration unit (Labtech, Villmergen, Switzerland) and
acetonitrile of high-performance liquid chromatography (HPLC) grade
was obtained from Fluka (Buchs, Switzerland). All other chemicals used
were fromMerck (Zug, Switzerland) and of the highest grade available.
Postmortem sample collection
Samples from blood vessels and alternative matrices were collected at
two time points (t1 and t2) after death according to Staeheli et al. (19) in
the course of the routine toxicological investigation from 23 deceased. In
short, after admission to the institute, immediately followed by postmor-
tem CT-imaging (t1) on a 128-slice scanner (Somatom Definition Flash,
Siemens Medical Solutions, Forchheim, Germany), introducer needles
were placed into the right heart ventricle, the right lung, the right lobe
of the liver, the right kidney, the spleen, subcutaneous adipose tissue of
the waist, muscle tissue at the upper thigh and the right femoral vein
using the virtobot system (19, 21). To verify the needle position, a sec-
ond CT scan was performed. A 1mL of blood was withdrawn from the
right heart ventricle and the femoral vein. Triplicate biopsy samples
were obtained from all alternative matrices detailed above (~20mg/
biopsy). These were immediately weighed into 2-mLMetal Bead Lysing
Matrix tubes (MP Biomedicals, Illkirch, France). The body fluids were
aliquoted into 2-mL Eppendorf Safe Lock Tubes (Schoenenbuch,
Switzerland) at 20μL each. Approximately 24 h after the virtobot sam-
pling procedure (mean 28 ± 15 h), samples from the same body regions
were collected during the autopsy (t2). Additionally, heart blood from
the left ventricle, urine, gastric content, cerebrospinal fluid and cerebel-
lum were collected and aliquoted into triplicates of 20 μL or 20mg,
respectively. All samples were stored at −20°C until analysis.
Sample preparation and quantitative liquid
chromatography tandem mass spectrometry analysis
All samples belonging to one case were extracted and analyzed on the
same day. Tissue and body fluid extraction as well as quantitative anal-
ysis was performed according to Staeheli et al. (22). In short, organ and
tissue samples were first homogenized using a Fast Prep®-24 Instrument
(MP Biomedicals, Illkirch, France). A two-step liquid–liquid extraction
(LLE) was performed with butyl acetate/ethyl acetate (1:1, v/v), step 1
at pH 7.4 and step 2 at pH 13.5. After combination of the extracts, all
samples were evaporated to dryness and reconstituted in 60 μL mobile
phase. Quantitative analysis was carried out on a Thermo Fischer
Ultimate 3000 UHPLC system (Thermo Fischer, San Jose, CA, USA)
coupled to a Sciex 5500 QTrap linear ion trap quadrupole mass spec-
trometer (Sciex, Darmstadt, Germany). Instrument settings were
adapted from Staeheli et al. (22), who previously validated a scheduled
multiple reaction monitoring (MRM) method for 83 analytes in 11
postmortem matrices including femoral blood (pB), heart blood (HB),
muscle, liver, kidney, spleen, lung, brain and adipose tissue. Validated
lower limits of quantification (LLOQ) and linear calibration ranges for
the studied analytes exemplified for blood were as follows: methadone
6 ng/mL (6–20,000 ng/mL), EDDP 2 ng/mL (2–16,000 ng/mL), fentanyl
0.8 ng/mL (0.8–2,000 ng/mL), tramadol 40 ng/mL (40–30,000 ng/mL),
ODMT 12 ng/mL (12–16,000 ng/mL), codeine 2 ng/mL (2–1,600 ng/
mL), oxycodone 2 ng/mL (2–2,000 ng/mL), hydrocodone 0.8 ng/mL
(0.8–2,000 ng/mL), dihydrocodeine 12 ng/mL (12–10,000 ng/mL).
Data analysis
Methadone distribution within the body was assessed with the concen-
tration ratio of each matrix to pB. Concentration differences between
sampling points t1 and t2 for all analytes were calculated as percentage
differences, defining the mean concentration at t1 as 100%. Statistical
significance was assigned based on the student’s t-test (two-tailed distri-
bution, heteroscedastic, P < 0.05).
For evaluation of the redistribution mechanisms statistical data
treatment was conducted. The percentage concentration change per
hour relative to the concentration at t1 was calculated for pB, HB and
spleen. Additionally, concentration ratios of adjacent matrices, poten-
tially exhibiting a concentration gradient, were formed. These included
ratios for muscle-to-pB, lung-to-HB, gastric content-to-spleen, lung-to-
HB and HB (left ventricle)-to-HB (right ventricle). Further, the HB-to-
pB ratio (representing the C/P-ratio) was formed. Nonparametric
Spearman correlation coefficients (two-tailed, 95% confidence interval)
were calculated using GraphPad Prism 6.0 (GraphPad Software, La
Jolla, CA, USA).
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Results and Discussion
Assessment of time-dependent distribution and PMR of opioids was con-
ducted within 12 cases of methadone intake (with detection of EDDP as
metabolite), four cases of fentanyl use, four cases of tramadol ingestion
(with detection of ODMT in two cases), and four, four, one and one
cases in which codeine, oxycodone, hydrocodone and dihydrocodeine
were quantified, respectively. Three cases within the methadone cohort
and one case of codeine intake had to be excluded due to the inability to
take blood samples at both time points in three cases and a systematic
sampling error that occurred in one case. Raw concentrations for all ana-
lyzed samples can be found in Table S1 within the Supplementary mate-
rial. The postmortem interval (PMI) in which all sampling procedures
were carried out ranged from 4.5 to 93 h across all evaluated cases.
Specific sampling time points and case circumstances as well as other
detected drugs are summarized in Table I. The evaluation of the PMR
behavior of non-opioid drugs was not part of the current study, so data
is not shown. Additionally, alcohol concentrations were not measured in
the sampled matrices so information was omitted for data evaluation.
Methadone and EDDP
Concentrations and redistribution of methadone
Methadone concentrations in pB at t1 ranged from 2.0 to 1,700 ng/mL
at 4.5 to 59 h postmortem. Distribution across body regions was rather
inhomogeneous, with highest concentrations detected in the liver, kid-
ney, lung, gastric content and urine. This supports previous findings of
Jantos and Skopp and summarized data by Baselt (14, 23). Muscle tis-
sue concentrations were closest to pB concentrations (Figure 1) in all
but one cases (muscle-to-pB-ratio: 18; classed as analytical outlier due
to very low overall methadone concentrations) when comparing all
sampled alternative matrices. This supports Holm and Linnet (13), who
proposed muscle and brain tissue as potential alternative matrices in
individual methadone cases where pB is not available.
Time-dependent concentration changes of methadone were evalu-
ated by comparing concentrations at t1 and t2 (Figure 2). In most cases,
either a significant increase (P < 0.05) or a minimal change in pB meth-
adone concentrations was observed (range −9 to +71%; mean +20%;
median +20%). This is suggestive of methadone being prone to PMR—
despite observed inter-individual variability—and in line with current
literature and its physiochemical properties (lipophilic, high protein
binding, pKa 8.6, Vd 4–7 L/kg) (4, 13, 14, 24). When evaluating the
concentration changes in the light of postmortem toxicological interpre-
tation, however, no case interpretation had to be altered with respect to
methadone concentrations at t1, so time-dependent concentration
changes within the studied timeframe can be considered irrelevant.
However, one case showed a 45% decrease of methadone pB con-
centration over time (case 6; 230–130ng/mL within 18 h). Compared
to the other methadone cases, the latter had a significantly later first
sampling point (PMI of 59 h in comparison to 4.5–30 h; Figure 2). It is
well recognized that decomposition of a body is a dynamic process that
commences almost immediately after death (5). At first, within the fresh
stage, the disintegration of cellular membranes and the release of cellu-
lar fluids in the body (autolysis) is the main driving force. As early as
Table I. Case circumstances including the postmortem interval (PMI) between death and t1, time between sampling points (dt), cause of
death, detected opioid and other drugs detected; cases 7, 8 and 12 were excluded for evaluation
Case PMI t1 (h) dt (h) Cause of death Opioid Other detected drugs
1 20 41 Internal bleeding Methadone Diazepam
2 30 23 Opioid intoxication Methadone Pipamperone, quetiapine, fluoxetine, diazepam
3 16 18 Acute heart failure Methadone, morphine Cocaine
4 6 18 Combined opioid and cocaine
intoxication
Methadone Cocaine, zopiclone
5 27 29 Opioid intoxication Methadone, morphine, 6-MAM Cocaine, alprazolam, flunitrazepam
6 59 18 Combined drug intoxication Methadone Methylphenidate, alprazolam, citalopram,
quetiapine, olanzapine, pipamperone
7 11 18 Central respiratory paralysis after
combined drug intoxication
Methadone, morphine Midazolam, diphenhydramine, 2-MAPB, MDAI
8 13 20 Hypoxic brain damage Methadone, morphine, codeine Midazolam, cocaine
9 5 23 Combined drug intoxication Methadone, hydrocodone Oxazepam, metamizol, fluoxetine
10 4.5 19 Combined drug intoxication Methadone, morphine,
6-MAM, codeine
Cocaine, diazepam, methylphenidate
11 28 46 Combined drug intoxication Methadone, morphine, 6-MAM Citalopram, methylphenidate, trazodone
12 30 16 Combined drug intoxication Methadone Diazepam, temazepam
13 63 25 Opioid intoxication Fentanyl, morphine Midazolam, citalopram, lorazepam, metamizol
14 42 51 Acute heart failure Fentanyl, morphine, oxycodone Zolpidem
15 33 24 Combined drug intoxication Fentanyl Cocaine, bupropion, flunitrazepam,
levomepromazine, midazolam
16 5 22 Acute heart failure Fentanyl
17 13 65 Opioid intoxication Tramadol Oxazepam, lorazepam, zopiclone
18 20 20 Acute heart failure Tramadol
19 7 67 Central regulatory failure after
headshot
Tramadol, oxycodone Bromazepam, diazepam
20 5 19 Hypoxic brain damage Tramadol Lorazepam
21 15 21 Acute heart failure Codeine, oxycodone
22 32 23 Combined drug intoxication Codeine, morphine, 6-MAM Quetiapine, trazodone
23 28 26 Combined drug intoxication Oxycodone, morphine Midazolam, quetiapine
6-MAM, 6-monoacetylmorphine; 2-MAPB, 1-(Benzofuran-2-yl-)-N-methylpropan-2amin; MDAI, 5,6-Methylendioxy-2-aminoindan.
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36–72 h after death, the additional destruction of soft tissues by micro-
organisms, such as bacteria and fungi, becomes the dominant decom-
posing factor within the bloated stage (25). These different stages of
decomposition within the specified timeframe can be brought into play
when evaluating the difference between case 6 and the remaining sam-
ple cohort. It indicates that, depending on the progress of decomposi-
tion, varying concentration change phenomena might be observed. This
stresses the importance of having reliable data on time of death and
sampling time available to prevent misinterpretation.
In adipose tissue samples, all but one case (case 3; +32%) showed a
methadone concentration decrease between t1 and t2 (range: −40 to
−13%; mean: −23%; median: −19%). Within the following matrices,
methadone concentration increases as well as decreases were observed
over time with no clear trend (Figure 2): HB (range: −16 to +78%;
mean +23%; median +19%), muscle (range: −85 to +33%; mean:
−8%; median: −4%), liver (range: −21 to +29%; mean: +3%; median:
+2%), lung (range: −68 to +62%; mean: −4%; median: −11%) and
spleen (range: −46 to +28%; mean: +6%; median: +6%). Kidney meth-
adone concentration changes between t1 and t2 also differed within the
case-cohort (range: −68 to +29%; mean: −21%; median: −17%), but
showed a stronger trend for concentration decreases over time compared
to the aforementioned matrices. However, as proposed by Staeheli et al.
(20), general drug concentration difference between kidney medulla and
cortex could be observed . Due to the applied sampling workflow in this
study, distinction between cortex and medulla during biopsy sampling
was not possible, which might influence the extent of observed time-
dependent concentrations changes, leading to potential variations.
Concentrations and redistribution of EDDP
In all but cases 11 of the methadone sample-cohort, the pharmaco-
logically inactive metabolite EDDP has been quantified as well.
EDDP pB concentrations at t1 ranged from 1.0 to 195 ng/mL. Similar
to methadone, EDDP peak concentrations across the studied matrices
were found in kidney, liver and urine in line with Jantos and Skopp
(14). Contrary to methadone, less significant (P < 0.05) time-dependent
concentration changes were observed for EDDP (Figure 3). Despite a
visible trend of drug concentration increases over time (range −3 to
+206%; mean +51%; median +32%), the current data cannot support
a strong tendency for PMR. The most extensive concentration increase
between t1 and t2 was observed for case 5 (+206%). However, the
overall EDDP concentration in this case was very low (mean over tripli-
cates = 1 ng/mL), so time-dependent concentration changes cannot
entirely be attributed to potential PMR, but analytical fluctuation close
to the LLOQ has to be considered as a potential reason for variability.
Additionally, five other cases showed non-significant concentration
changes, as either variability within triplicates were too big or EDDP
concentration increases were only minimal. Following this, EDDP time-
dependent concentration changes can also be classified as non-relevant
for toxicological case interpretation.
Analogous to methadone, the following matrices showed EDDP
concentration increases as well as decreases over time with no clear
trend: muscle (range: −70 to +82%; mean: +19%; median: +32%),
liver (range: −26 to +524%; mean: +85%; median: +17%), kidney
(range: −70 to +46%; mean: −17%; median: −19%), lung (range:
−53 to +103%; mean −5%; median: −24%), adipose tissue (range:
−44 to +183%; mean: +43%; median: +25%), spleen (range: −36 to
+87%; mean: +25%; median: +7%). The majority of HB concentra-
tions increased between t1 and t2 (range: +16 to +104%; mean:
+34%; median: +20%), with only case 2 decreasing in the studied
time period (−24%).
Redistribution mechanisms
Based on the observed significant time-dependent concentration changes
of methadone within the sample cohort, potential redistribution mechanisms
Figure 1. Distribution of methadone across sampled tissues; displayed as concentration ratio to femoral blood (pB); each dot represents one case; the line repre-
sents the median ratio; in cases where a concentration ratio at t1 was not available, concentration ratio at t2 was displayed (HB (l), urine, cerebellum and gastric
content); the dotted line indicates equal concentration to pB; cases 7, 8 and 12 were excluded for evaluation.
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Figure 2. PMR of methadone in femoral blood, heart blood (right ventricle), muscle, liver, kidney, spleen, lung and adipose tissue displayed as concentration vs.
postmortem interval (PMI). Each dot represents one sample of the triplicate measurements. The mean concentrations at each sampling time point were con-
nected with a line in each case.
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were evaluated. A frequently used marker for the potential occurrence
of PMR is a C/P-ratio >1 (6). Correlating the C/P-ratio of methadone
to the concentration change in pB within the current sample cohort, a
strong positive correlation was found (Figure 4a). However, only two
cases at t1 showed a C/P-ratio >1 (case 5: 1.95; case 9: 1.36), indicating
a weak overall potential of methadone to undergo PMR. This suggests
that the C/P- ratio alone might not be a valuable indicator for postmor-
tem concentration changes in case of methadone, as it omits time-
dependency.
To evaluate the findings of recent studies, particularly the possibil-
ity of methadone being redistributed by passive diffusion should be
assessed with the current dataset (14, 16). Concentration ratios of
adjacent tissues were correlated to methadone concentration changes
(Figure 4). Adapted from Staeheli et al. (20), inter-individual PMI dif-
ferences were compensated by dividing concentration changes through
the corresponding sampling interval, despite the fact that linearity of
concentration changes across varying PMIs could not be assumed. As a
distinct concentration gradient between muscle samples from the upper
thigh and pB was found in the majority of cases (Figure 1), observed pB
concentration increases over time might have been caused by metha-
done diffusion from adjacent muscle tissue (1). Spearman correlation of
the muscle-to-pB-ratio at t1 against concentration changes in pB over
time, supports this hypothesis, as a strong positive correlation was
observed (Figure 4b). Even excluding cases with very low overall meth-
adone concentrations (cases 5 and 11) as potential analytical outliers, a
strong positive correlation between the two variables was still found.
However, diffusion along the blood vessels cannot be excluded as con-
centrations distal or proximal to the sampling point were not investi-
gated (20). Further sources of PMR that are discussed in literature are
concentration gradients leading to potential passive diffusion between
lung and cardiac vessels, and from gastrointestinal tract into surround-
ing organs (e.g., spleen) (1, 16). Spearman correlations were carried out
Figure 2. Continued
Figure 3. PMR of EDDP in femoral blood and muscle displayed as concentration vs. postmortem interval (PMI). Each dot represents one sample of the triplicate
measurements. The mean concentrations at each sampling time point were connected with a line in each case.
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Figure 4. Evaluation of redistribution mechanisms of methadone in femoral blood (pB), displayed as the concentration change in pB [in percent per hour (%/h)]
against the C/P-ratio (a) and the muscle-to-pB concentration ratio (b). Evaluation of redistribution mechanisms of methadone in heart blood (HB), displayed as
the concentration change in HB against the lung-to-HB concentration ratio (c) and the HB concentration ratio between left and right ventricle against lung-to-HB
concentration ratio (e). Further, the methadone concentration change in spleen was displayed against the gastric content-to-spleen ratio (d). Additionally, evalu-
ation of the redistribution mechanism of EDDP in pB is shown as the concentration change in pB against the mucle-to-pB concentration ratio (f).
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and are displayed in Figure 4. A very weak positive correlation was
found for the concentration ratio between lung and HB against time-
dependent concentration changes in HB from the right ventricle
(Figure 4c). This suggests redistribution from lung tissue to the right
heart ventricle is possible but might not be occurring extensively. In
contrast to this, correlation of the lung-to-HB-ratio with the concentra-
tion ratio between HB from the left and the right ventricle showed a
strong positive correlation (Figure 4e). This supports the theory of redis-
tribution from the lung to the left heart via the pulmonary veins as pro-
posed by Jantos and Skopp (14). Diffusion from gastric content to
spleen as a closely situated organ to the stomach also seems possible
based on a weak positive correlation found by spearman correlation
(Figure 4d), although this is likely to not be relevant in most case
interpretations.
In contrast to methadone, spearman correlation showed only a
very weak/no potential for EDDP to be redistributed after death from
thigh muscle tissue to pB (r = 0.048; Figure 4e). Further investigation
of distribution mechanisms utilizing spearman correlation showed
non-significant correlation between the tested variables (data not
shown). This supports the overall finding detailed above, that a strong
tendency of EDDP to undergo PMR cannot be supported. Although
Jantos and Skopp concluded from their study, that EDDP does
undergo PMR similar to methadone, they also proposed a weakness
of EDDP to pass cell barriers (14). Based on the blood brain barrier
this hypothesis can be supported by the current study, as the EDDP
concentrations found in the brain were very low in comparison to the
methadone concentration found in the same brain regions (taking
into account the overall methadone/EDDP ratio within the body).
Nevertheless, besides diffusion processes, putrefaction bacteria can
also significantly affect drug concentration (26). The potential effect
of these on EDDP time-dependent concentration changes were not
studied in the course of this project.
Fentanyl
Within the four evaluated cases of fentanyl use, the concentration range
in pB at t1 was between 0.4 and 11.1 ng/mL across a PMI between
death and t1 of 5–63 h with 22–51 h between sampling points. The
mode of fentanyl application for cases 14 and 15 was a continuous
patch, whereas in cases 13 and 16 fentanyl was given during intensive
care medical treatment several hours before death. Exact timings are
not known, but complete distribution of fentanyl within the body was
assumed at time of death. In accordance with the findings of Olson
et al. (11), fentanyl peak tissue concentrations were found in the liver
and kidney. Based on the physiochemical properties of fentanyl (Vd of
3–8L/kg, pKa of 8.4, 80–86% protein bound, highly lipophilic) (18, 27),
an extensive redistribution of the drug after death is expected, which is
supported by our findings. As displayed in Figure 5, fentanyl showed
significant time-dependent concentration increases in the peripheral
blood in three out of four cases (range: +24 to +117%; mean: +62%;
median: +74%). This confirms a high tendency for PMR even in
peripheral sites as also reported in previous studies (11, 12, 18, 27, 28).
Several publications discuss the unsuitability of the C/P-ratio in the con-
text of fentanyl and propose the use of a liver-to-peripheral blood ratio
(L/P-ratio) as a better marker to assess PMR (12, 18). This can only be
supported in parts with the current study, as a high C/P-ratio of 2.5 at
t1 and of 2.0 at t2 was already suggestive of an extensive PMR.
However, it has to be stated that the L/P-ratio was considerably higher
with 10.1 at t1 and 8.0 at t2, which does not contradict the aforemen-
tioned publications.
Other opioids
Other opioids such as tramadol, codeine, hydrocodone and oxycodone
showed no clear trend in terms of PMR within the current evaluated
dataset. Significant time-dependent tramadol concentration increases as
well as decreases in pB were observed (+32%, +24%, +19%, −51%).
In line with Han et al. (6), this suggests non-consistent PMR changes.
Generally, the literature proposes a low-to-moderate tendency for tra-
madol to undergo PMR (6, 29, 30), which is in line with the extent of
the measured concentration changes. Additionally as proposed by
Costa et al. (29), a low tendency of ODMT (the main active metabolite
of tramadol) for PMR can be concluded for the studied PMI timeframe;
ODMT concentration changes of +20, +7 and −2% were detected in
pB over time.
Similarly, the four cases positive for codeine in the current sample
cohort, showed a concentration increase (+17%) and concentration
decreases (−18%, −29%, −46%) in pB between sampling points. In
three out of four cases the metabolite morphine was also detected. The
PMR of morphine was already evaluated by Staeheli et al. and will not
be extensively discussed here. Interestingly, morphine was found to
undergo significant postmortem changes, which was not observed for
codeine, despite structural similarities between the two analytes.
Overall only a weak tendency of codeine to undergo time-dependent
PMR in three out of four cases was found, although the case number is
currently too small to draw definite conclusions. Contrary, the mean
C/P-ratio was 2.4, suggesting that codeine might exhibit PMR. A com-
parable C/P-ratio (2.6) of codeine was previously found by Tolliver
et al. (31), who concluded that five of their seven studied codeine cases
were affected by PMR. The discrepancy between time-dependent con-
centration changes and measured C/P-ratio again raises the question of
the suitability of the C/P-ratio when describing a time-dependent phe-
nomenon like PMR. This is already proposed by Han et al. (6), who
found a high C/P-ratio for codeine, but pointed out that a high C/P-
ratio does not always reflect extensive PMR.
Saitman et al. (32) followed the same opinion when stating that
there is little agreement as to what the C/P-ratio defines in terms of
Figure 5. PMR of fentanyl in femoral blood displayed as concentration vs.
postmortem interval (PMI). Each dot represents one sample of the triplicate
measurements. The mean concentrations at each sampling time point were
connected with a line in each case.
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PMR. Therefore, they focused on the L/P-ratio, when evaluating the
potential for redistribution of hydrocodone. Based on this measure they
found a low potential of hydrocodone to exhibit PMR (32). The one
hydrocodone case in the current sample cohort supports these findings,
as no concentration change in pB over time was observed (c(t1) =
1.9 ng/mL, c(t2) = 1.9 ng/mL) with a C/P-ratio of 1.2 and a L/P-ratio of
1.5 at t1. Dihydrocodeine, a commonly encountered metabolite of
hydrocodone, was also detected in the aforementioned case. Here, a
non-significant concentration increase between sampling point 1 and 2
of +10% was observed (c(t1) = 28 ng/mL, c(t2) = 31 ng/mL), with a
C/P-ratio of 1.6 and a L/P-ratio of 2.2. Based on Saitman et al., this
again indicates a low tendency of dihydrocodeine to undergo PMR (32).
To the best of our knowledge, there is currently no publication
available that focuses on the likelihood of oxycodone to exhibit PMR.
Han et al. (6) report one case of oxycodone detection with a C/P-ratio
of 1.04. The dataset of the current study includes four oxycodone cases,
which showed no consistency in terms of PMR. pB concentrations
showed increases as well as decreases over time (+93%, +14%, +10%
(below LLOQ), −5%) but no definite conclusion could be drawn due
to the small case number.
Limitations of the study
Overall, the current study is not without limitations, which include a
small case number per analyte and slightly varying sampling time points
across cases. By evaluating the data in a time-dependent manner, the
latter was attempted to be corrected for. Further it has to be noted that
due to organizational reasons the very early postmortem phase could
not be studied (i.e., the timeframe between death and admission to the
institute) and storage conditions between t1 and t2 might not accurately
represent authentic environmental conditions of a deceased as body’s
were kept at 7°C between sampling points. Nevertheless, the presented
results provide valuable information that aid in the understanding of
PMR of opioids and are a unique possibility to study time-dependency
of redistribution mechanisms within the human body.
Conclusion
Significant time-dependent methadone concentration increases in pB
indicate the occurrence of PMR, however, concentration changes were
regarded as not relevant with respect to forensic case interpretation.
This also holds true for EDDP, which showed a less significant trend
for PMR. Investigating potential redistribution mechanisms, passive dif-
fusion along the muscle-to-pB concentration gradient seems likely for
methadone, but not for EDDP. Results for fentanyl support the current
literature and suggest that extensive PMR of the drug is expected.
Other opioids such as tramadol, codeine, hydrocodone and oxycodone
show no consistent trend for significant PMR. Overall, CT-guided
biopsy sampling proved to be a valuable tool for the investigation of
PMRmechanisms.
Supplementary data
Supplementary material is available at Journal of Analytical Toxicology
online.
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